[ad_1]
SINGAPORE and WALL, NJ, December 15, 2022 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKII ), an innovative provider of identity and access management (IAM) and identity-based biometrics (IBB) solutions, today announced a strategic partnership with Singapore-based Progreso Networks & Security Pte. Ltd. to provide IAM solutions to customers across Southeast Asia.
BIO-key solutions include BIO-key PortalGuard®, a unified IAM platform that offers more flexible multi-factor authentication (MFA), single sign-on (SSO), and self-service password reset (SSPR) options than any other access management solution. PortalGuard is the only IAM platform that offers identity-based biometric authentication, using a single, centralized biometric identity to verify the person completing the transaction. This means that trust can be established that the person is the correct person, rather than just verifying their device, password or token. PortalGuard also consolidates multi-point solutions under centralized security policies so users can take a holistic approach to their access management strategy.
Progreso is a value-added distributor and professional services provider of cybersecurity and network solutions in public key infrastructure (PKI) and endpoint security, with particular expertise in identity management, data protection, key management systems, hardware security modules and certificates. Through its robust SI partner network, Progreso has gained a strong foothold in the government sector, protecting critical infrastructure from cyber threats.
“We are very excited to seal this partnership with BIO-key and offer their award-winning IAM platform and state-of-the-art solutions,” said Victor Tang, Managing Director, Progreso. “BIO-key has a proven track record of successfully delivering IAM projects to enterprises in the US and European markets, and we want to duplicate their successes in Singapore and Southeast Asia.”
“As organizations of all sizes grapple with cybersecurity, risk and privacy challenges, it’s critical that we deliver the solutions that businesses need in every part of the world,” said Alex Rocha, Managing Director – EMEA, BIO-key. “Our partnership with Progreso is an essential step in providing identity solutions to customers in Southeast Asia. With a huge shortage of cybersecurity professionals across Asia Pacific, BIO-key’s easy-to-deploy IAM solutions and Progreso’s network of system integrators are sure to be a winning combination.”
To learn more about Progreso, visit Progreso’s website. For information about BIO-key and their PortalGuard and Identity-Bound Biometric solutions, visit the BIO-key website.
About BIO-key International, Inc. (www.BIO-kei.com)
BIO-key has more than two decades of expertise in providing authentication technology to thousands of organizations and millions of users and is revolutionizing authentication with biometric identity and access management (IAM) solutions that target multiple factors, including its PortalGuard IAM solution that provides convenient and secure access devices, information, applications and high-value transactions. BIO-key’s patented software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premises and cloud-based Identity-as-a-Service (IDaaS) solutions, as well as customized enterprise solutions.
About Progreso Networks & Security Pte. doo (www.progreso.com.sg)
Progreso is a value-added distributor (VAD) for cybersecurity and network solutions offering professional services and solutions in public key infrastructure (PKI) and endpoint security. Progreso adds value to our System Integrator (SI) partners by providing strong expertise in pre-sales and post-sales support for all our products and solutions. Progreso’s areas of expertise include Hardware Security Modules (HSM), Key Management Systems (KMS), Data Encryption/Tokenization, Identity Access Management (IAM) and Data Loss Prevention (DLP). Through strong partnerships with our NE partners, Progreso has gained a strong foothold in the government sector, where we are committed to protecting the nation’s most critical infrastructure from cyber threats.
BIO-key Safe Harbor statement
All statements contained in this press release other than statements of historical fact are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate”, “project”, “intend”, “expect”, “anticipate”, “believe” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, assumptions made by management and information currently available to management pursuant to the provisions of the Safe Harbor Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that could cause actual results to differ materially from those included or implied in such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenues; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the market; continued services from our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products in general and our products under development; the duration and severity of the current COVID-19 coronavirus pandemic and its impact on our business operations, sales cycles, personnel and geographic markets in which we operate; product development delays and statements of assumptions underlying any of the foregoing, as well as other factors listed under the heading, see “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 and other submissions to the Securities Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revisions to these forward-looking statements, whether as a result of new information, future events or otherwise. In addition, there may be other factors of which the Company is not currently aware that may affect the matters discussed in the forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the outbreak of the coronavirus on economic conditions and the industry in general and the financial position and operations. In particular, the results of our company are material, change quickly and cannot be predicted.
Activate with BIO-key
Facebook – corporate: https://vvv.facebook.com/BIOkeiInternational/
LinkedIn – Corporate: https://vvv.linkedin.com/company/bio-kei-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keiIR
StockTweets: BIO_keiIR
Media contact
Erin Knapp
A thing in the name of BIO-key
BIO-Key@matternov.com
Investor contacts
William Jones, David Collins
IR catalyst
BKII@catalist-ir.com
212-924-9800
[ad_2]
Source link
